Concepedia

Philippe Szapary

PS

42

Publications

9.2K

Citations

36

H-Index

2003

Active since

Affiliations

Janssen (United States)(Current)

University of Pennsylvania

Icahn School of Medicine at Mount Sinai

University of California San Diego

Dalhousie University

Philippe Szapary is an author at Janssen (United States) specializing in medicine, dermatology, and clinical trials.

Top concepts

Publications per year

2003–2019

42

Publications

42

A Randomized Trial of a Low-Carbohydrate Diet for Obesity

Gary D. Foster, Holly R. Wyatt, James O. Hill et al. · New England Journal of Medicine · 2003 · 1.8K citations

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Kim Papp, Richard G. Langley, Mark Lebwohl et al. · The Lancet · 2008 · 1.3K citations

, , +7

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

Bruce E. Sands, William J. Sandborn, Remo Panaccione et al. · New England Journal of Medicine · 2019 · 1.1K citations · Full text

Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis

Howard Sofen, Stacy Smith, Robert Matheson et al. · Journal of Allergy and Clinical Immunology · 2014 · 298 citations · Full text

A Phase 2 Trial of Guselkumab versus Adalimumab for Plaque Psoriasis

Kenneth B. Gordon, Kristina Callis Duffin, Robert Bissonnette et al. · New England Journal of Medicine · 2015 · 291 citations · Full text

Rows per page

1–5 of 42